Evidence map›Paper›PMID 39846607›Full record

ArticleHematology reports2025

AntiCD30-Conjugated Antibody Plus Standard BEAM as Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Systemic Anaplastic Large Cell Lymphoma.

Panayotis Kaloyannidis, Basmah Al-Charfli, Biju George, Charbel Khalil, Nour Al-Moghrabi, Samar Mustafa, Dima Ibrahim, Mohammed Alfar, Firuz Ibrahim, Bassam Odeh and 2 more

Abstract readCase Reports
In one paragraph

Article in Hematology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Panayotis KaloyannidisAdult Haematology & Cellular Therapy Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.ORCID 0000-0002-4773-041X
Basmah Al-CharfliAdult Haematology & Cellular Therapy Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Biju GeorgeAdult Haematology & Cellular Therapy Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Charbel KhalilAdult Haematology & Cellular Therapy Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.ORCID 0000-0001-7740-6963
Nour Al-MoghrabiAdult Haematology & Cellular Therapy Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Samar MustafaNursing Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Dima IbrahimInfectious Diseases Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Mohammed AlfarPharmacy Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Firuz IbrahimNuclear Medicine Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Bassam OdehHematopathology Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Mohammed DaryahyaNursing Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Philip ShaboOperations Department, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autologous peripheral blood stem cell transplantationbrentuximab vedotinconditioning regimennon-Hodgkin lymphomasystemic anaplastic large cell lymphoma

Identifiers

PMID39846607
PMCPMC11755634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.